Decriminalization: beyond the buzzword
Up to now, drug policies in Canada have failed to protect the health and human rights of people who use drugs. Criminalization puts, more than ever, people who use drugs […]
Up to now, drug policies in Canada have failed to protect the health and human rights of people who use drugs. Criminalization puts, more than ever, people who use drugs […]
The Centre of Expertise and Collaboration in Concurrent Disorders of the RUISS of the University of Montreal invites you to its annual scientific activity under the theme Concurrent disorders : […]
Les Presses de l'Université Laval vous invitent au lancement virtuel du livre « À la rencontre de la relation d'aide difficile » sous la direction de Michel T. Giroux qui […]
Webinaire en français organisé par CATIE en partenariat avec CanHepC portant sur les implications de la COVID-19 sur les efforts d’élimination et pour les personnes vivant avec le VHC. Avec […]
Friday 5, 2021 - 1pm to 2pm EST Calendar entry. At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that […]
Programmation détaillée Mise en contexte de la situation des surdoses au Québec Qu’est-ce qui circule dans le marché illicite au Québec et ce que ces données nous révèlent ? La […]
10am – noon Pacific 11am – 1pm Mountain 12-2pm Central 1-3pm Eastern 2-4pm Atlantic 2:30-4:30pm Newfoundland & Labrador Public health in Canada responded dramatically to […]
At the request of the Government of Canada, the Canadian Research Initiative in Substance Misuse (CRISM) developed 6 national guidance documents that address the urgent needs of people who use substances, as well […]
The Harm Reduction Symposium will bring together many stakeholders to raise awareness, educate, and enhance harm reduction collaboration. CALL TO ACTION: As a community, it is our responsibility to […]
Injectable opioid agonist treatment (iOAT) is a safe, life-saving, and cost-effective treatment option for individuals with severe opioid dependence. It is also virtually unavailable in Ontario. The need for iOAT […]